YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Healthcare Technology for Providers Stocks Q2 Recap: Benchmarking Omnicell (NASDAQ:OMCL) As the craze of earnings season draws to a close, here's a look back at some of the most exciting (and some less so) results from Q2. Today, we are lo…
Healthcare Technology for Providers Stocks Q2 In Review: Astrana Health (NASDAQ:ASTH) Vs Peers Wrapping up Q2 earnings, we look at the numbers and key takeaways for the healthcare technology for providers stocks, including Astrana Health (…
1 of Wall Street's Favorite Stocks for Long-Term Investors and 2 We Find Risky Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it's important to remain skeptical…
Healthcare Technology for Providers Stocks Q2 Teardown: Privia Health (NASDAQ:PRVA) Vs The Rest Looking back on healthcare technology for providers stocks' Q2 earnings, we examine this quarter's best and worst performers, including Privia…
1 Value Stock with Promising Prospects and 2 That Underwhelm Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they're out of favor. The key risk, however, is…
Unpacking Q2 Earnings: Hims & Hers Health (NYSE:HIMS) In The Context Of Other Healthcare Technology Stocks Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let's have a look at Hims…
1 Healthcare Stock Worth Your Attention and 2 We Brush Off Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have been rewarded lately as h…
Reflecting On Healthcare Technology Stocks' Q2 Earnings: GoodRx (NASDAQ:GDRX) Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let's have a look at GoodRx (NASDAQ:GDRX) and its peer…
3 Stocks Under $10 with Questionable Fundamentals Stocks trading in the $1-10 range are generally smaller players with less risk than their penny stock counterparts. But that doesn't mean the underlying businesses are cheap, and we advise…
Boeing upgraded, Under Armour downgraded: Wall Street's top analyst calls The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compi…
Key Points Interested in Evolent Health, Inc? Here are five stocks we like better. Evolent raised its 2026 outlook after Q2 revenue rose 31% sequentially to $653 million and adjusted EBITDA increased 27% to $28 million. Full-year revenue g…
Evolent Health, Inc. Q2 2026 Earnings Call Summary - Moby Strategic Execution and Market Dynamics Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick…
1 Small-Cap Stock for Long-Term Investors and 2 We Brush Off Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have…
Tempus AI (TEM) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to a loss of $0.22 per share a year ago. These figures are adjusted for non-recurring items. This quart…
Koninklijke Philips N.V. PHG reported second-quarter 2026 adjusted earnings of €0.49 per share, up 36.1% from €0.36 a year ago. The improvement reflected higher sales, productivity measures and a U.S. tariff refund benefit. Sales increased…
Companies that are actually using AI and not just talking about it are worth investors' attention. - Getty Images/iStockphoto The "Mag Seven" stocks have become the "Bag Seven" — or worse. That was fun while it lasted. Through the first ha…
3 Unprofitable Stocks with Questionable Fundamentals Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, these businesses risk running o…
Veeva Systems Inc. VEEV continues to benefit from demand for life sciences cloud platforms, with steady progress in Vault CRM migrations and ongoing expansion across R&D and Quality solutions. Management’s fiscal 2027 outlook calls for mid…
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q1. Today, we are looking at healthcare technology for providers stocks, starting with Privia Health (NASDAQ:…
(RTTNews) - Thursday's top gainers include Veru, following a Novo Nordisk collaboration; Health Catalyst, following a divestment of its revenue workflow and analytics software business; Absci, ahead of clinical trial readouts; and Alvotech…
Healthcare operations leader with more than a decade of managed care and clinical operations experience joins Accuity to support continued growth. MOUNT LAUREL, N.J., June 2, 2026 /PRNewswire/ -- Accuity, an AI-driven clinical revenue inte…
Key Points Rubicon Founders purchased 175,142 shares of Privia Health Group; estimated trade size of $3.95 million based on quarterly average pricing. Post-trade, Rubicon Founders holds 5,948,664 shares valued at $122.36 million. Privia He…
What happened According to an SEC filing dated May 15, 2026, Rubicon Founders LLC increased its holdings in Privia Health Group(NASDAQ:PRVA) by 175,142 shares during the first quarter. The estimated transaction value was $3.95 million, cal…
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have caused the industry to lag…
Over the last six months, Evolent Health’s shares have sunk to $3.96, producing a disappointing 5.7% loss - a stark contrast to the S&P 500’s 9.1% gain. This might have investors contemplating their next move. Is now the time to buy Evolen…
As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the healthcare technology for providers industry, including Astrana Health (NASDAQ:ASTH) and its peers. The healthcare techn…
As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the healthcare technology for providers industry, including Omnicell (NASDAQ:OMCL) and its peers. The healthcare technology…
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher volatility and risk, as their smaller size…
Wrapping up Q1 earnings, we look at the numbers and key takeaways for the healthcare technology stocks, including Hims & Hers Health (NYSE:HIMS) and its peers. Healthcare technology companies develop software, data analytics, and digital p…
Rosarium Health, a Black-founded healthtech company supporting in-home care for aging populations, has secured new funding. Cameron Carter is the founder and CEO of the company, which was inspired by his years spent in value-based healthca…
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside risk because they lack the scale and stay…
Evolent Health logo Key Points Interested in Evolent Health, Inc? Here are five stocks we like better. Evolent Health said first-quarter 2026 results were in line with expectations, with revenue of $496 million and adjusted EBITDA of $22 m…
Image source: The Motley Fool. DATE Thursday, May 7, 2026 at 8 a.m. ET CALL PARTICIPANTS Chief Executive Officer — Seth Blackley Chief Financial Officer — Mario Ramos Full Conference Call Transcript Seth Blackley: Good morning, and thank y…
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the healthcare technology for providers industry, including Privia Health (NASDAQ:PRVA) and its peers. The healthcare techno…
Health insurance provider Elevance Health (NYSE:EVH) reported Q1 CY2026 results topping the market’s revenue expectations , with sales up 2.9% year on year to $50.18 billion. Its non-GAAP profit of $12.58 per share was 16.4% above analysts…
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how healthcare technology stocks fared in Q4, starting with GoodRx (NASDAQ:GDRX). Healthcare technology…